| Tag | Content |
|---|
EnhancerAtlas ID | HS026-00345 |
Organism | Homo sapiens |
Tissue/cell | CNCC |
Coordinate | chr1:16439200-16440100 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr1:16439464-16439474 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr1:16439464-16439474 | GGCACGTGCC | - | 6.02 | | Nr5a2 | MA0505.1 | chr1:16439671-16439686 | GGGGTCAAGGCCAGG | + | 6.26 | | ZNF263 | MA0528.1 | chr1:16439314-16439335 | CCCCCACTTCTTTCCTCCCTC | - | 6.04 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_46140 | chr1:16437741-16440213 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I016111 | chr1 | 16437821 | 16439862 |
|
Enhancer Sequence | CTAATTTAGA TTCCTGGGTT TATGGCAGGA AGCGCAGCAA GGCTGACACT GTAATTAAGG 60
CGATTCCTGA GGCTGCGGGA GGAGGCAGGC AGAGGAGCCC ACCACAGGGC TGGGCCCCCA 120
CTTCTTTCCT CCCTCTGCCA GAAGCCCCAA CCTCAGAGCT TCAACAGGCT CCTCTGCCTT 180
AGAGCCCAGG CTCTGGAACT CCACTTTGCA TCCCAGGAAA CCAGAGATGG GCAGCTGCAT 240
CCCAAGGGTC ACACAGCACA CGATGGCACG TGCCTGAGCC ACCCCTGGGG GCCTCCCTCT 300
GCCAACTGTG GTCCAGCTGG GGGTGCAGAG AGAGCCCAGA TACATGGCTT CTTTGTTCCA 360
TCCACCCCGG ATCCCAGGTC CCTCTTCTCT GAGTCCCCCT CCCCCTGCAT TCCTGAGGTG 420
TCTGGGCAGA GTCCGGCAGG GCTGTGGCAG GAGGGGCAGC TCCCCCACTC AGGGGTCAAG 480
GCCAGGGCAG CAGCCGGGCC TGAGCACCGA GCAGTCTCCA GCTGAGGCCT GGGGCTGTGC 540
TGGGTCTGTA GTGCCCAGGG GGAGACTTGG GGGCTCACTG TCCCCCTCCC TACCCATGGA 600
CTGGAGCTTT AATTCTCACT CTGCTCCTCT GGGTGACCCT GGGCCTCTCT TCTTGGAGTC 660
TCAGTGTTCT CATCTATACA AAGGGTGCCA CCATCACCGG GGAGGCCAGT TCTCCTTCCT 720
GCCCTGGGCT GAGCTGGTGG TGCGGCCCCA CCAGAGCACT TAGGTGGCCT TCACCAGCCT 780
TCCCTGATTC TGGTCCGTGC CCAGTCAGGC TCTGTGGCCT TGGGCAACCC CTGCTCTCTG 840
GGCCTCCACA CCTTCTTTAG TAAAAATGAG GGGCTTGGAC AGAGTCAGGG TCTCCCACTC 900
|
